ORIC Pharmaceuticals Inc (ORIC)
8.45
-0.32
(-3.65%)
USD |
NASDAQ |
Apr 24, 11:31
ORIC Pharmaceuticals Cash from Investing (TTM): -43.40M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -43.40M |
September 30, 2023 | -36.07M |
June 30, 2023 | 21.08M |
March 31, 2023 | -5.81M |
December 31, 2022 | -109.25M |
September 30, 2022 | -137.20M |
June 30, 2022 | -101.44M |
March 31, 2022 | 27.13M |
December 31, 2021 | 158.44M |
Date | Value |
---|---|
September 30, 2021 | 66.83M |
June 30, 2021 | -92.93M |
March 31, 2021 | -175.50M |
December 31, 2020 | -215.96M |
September 30, 2020 | -124.76M |
June 30, 2020 | -0.288M |
March 31, 2020 | -0.479M |
December 31, 2019 | -0.768M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-215.96M
Minimum
Dec 2020
158.44M
Maximum
Dec 2021
-45.32M
Average
-36.07M
Median
Sep 2023
Cash from Investing (TTM) Benchmarks
Geron Corp | -180.32M |
Verastem Inc | -44.45M |
Karyopharm Therapeutics Inc | 7.94M |
Syndax Pharmaceuticals Inc | 117.61M |
Arvinas Inc | 203.50M |